03 | METHODOLOGY
For clients that engage Skysis early in clinical development, Skysis assists in building the payer value story framework, identifying clinical endpoints, formulation, and dosing included in a product’s label that support a premium value. Skysis also identifies the clinical and commercial data necessary to support the unmet need within the disease and the beneficial economic impact of the product for successful negotiation with payers. For clients that start later, Skysis’ market access experts will triage the situation, expertly leveraging Skysis’ panel of payer executives for relevant and actionable insights on the treatment options, appropriate analogs for payer management strategies, and how the product’s target product profile (label expectations) might be managed, or utilization otherwise restricted. A plan is then established to address the highest priority areas of the payer value story.